Oppenheimer Holdings, Inc. (NYSE:OPY) Short Interest Up 72.3% in February

Oppenheimer Holdings, Inc. (NYSE:OPYGet Free Report) was the target of a large growth in short interest in February. As of February 13th, there was short interest totaling 35,788 shares, a growth of 72.3% from the January 29th total of 20,775 shares. Based on an average daily trading volume, of 71,175 shares, the short-interest ratio is presently 0.5 days. Currently, 0.5% of the company’s stock are sold short. Currently, 0.5% of the company’s stock are sold short. Based on an average daily trading volume, of 71,175 shares, the short-interest ratio is presently 0.5 days.

Analysts Set New Price Targets

Several brokerages have weighed in on OPY. Cantor Fitzgerald cut Oppenheimer to a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen downgraded shares of Oppenheimer from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Oppenheimer in a research report on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

View Our Latest Research Report on Oppenheimer

Institutional Investors Weigh In On Oppenheimer

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue acquired a new position in shares of Oppenheimer during the 3rd quarter worth approximately $31,000. Arax Advisory Partners lifted its position in Oppenheimer by 47,700.0% during the fourth quarter. Arax Advisory Partners now owns 478 shares of the financial services provider’s stock worth $35,000 after buying an additional 477 shares in the last quarter. Torren Management LLC acquired a new position in Oppenheimer during the fourth quarter worth $38,000. Barclays PLC purchased a new stake in Oppenheimer in the 4th quarter valued at $40,000. Finally, Clearstead Advisors LLC grew its holdings in Oppenheimer by 193.9% in the 4th quarter. Clearstead Advisors LLC now owns 629 shares of the financial services provider’s stock valued at $45,000 after buying an additional 415 shares in the last quarter. Hedge funds and other institutional investors own 32.26% of the company’s stock.

Oppenheimer Trading Down 4.6%

OPY traded down $4.16 during midday trading on Friday, hitting $86.16. 36,001 shares of the company were exchanged, compared to its average volume of 62,530. The company’s 50 day simple moving average is $80.94 and its 200 day simple moving average is $74.39. The firm has a market capitalization of $906.42 million, a price-to-earnings ratio of 6.61 and a beta of 1.20. Oppenheimer has a 1-year low of $49.26 and a 1-year high of $94.10.

Oppenheimer (NYSE:OPYGet Free Report) last posted its earnings results on Friday, January 30th. The financial services provider reported $6.51 earnings per share for the quarter. The firm had revenue of $472.63 million during the quarter. Oppenheimer had a net margin of 9.06% and a return on equity of 16.55%.

Oppenheimer Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were given a dividend of $0.18 per share. The ex-dividend date was Friday, February 13th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Oppenheimer’s dividend payout ratio (DPR) is 5.52%.

About Oppenheimer

(Get Free Report)

Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.

In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.

Read More

Receive News & Ratings for Oppenheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oppenheimer and related companies with MarketBeat.com's FREE daily email newsletter.